HOLT-ED: Holter-monitoring in End-stage Renal Disease
NCT: NCT04876963 · COMPLETED
Brief Summary
The main objective of this prospective cohort study is to assess arrhythmia burden and glycemic variability in a multicenter cohort of patients with end-stage renal disease using a sufficient observation period in order to identify arrhythmia burden and type and characterize associations with patient characteristics and dialysis treatment, glycemic variability and subsequent risk of adverse outcomes.
Frequently Asked Questions
What is HOLT-ED: Holter-monitoring in End-stage Renal Disease?
HOLT-ED: Holter-monitoring in End-stage Renal Disease is a clinical trial registered under NCT04876963. Current status: COMPLETED.
What is the status of NCT04876963?
The current status of NCT04876963 (HOLT-ED: Holter-monitoring in End-stage Renal Disease) is: COMPLETED.
When did HOLT-ED: Holter-monitoring in End-stage Renal Disease start?
HOLT-ED: Holter-monitoring in End-stage Renal Disease started on 2021-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.